United States · FDA National Drug Code directory
Naphazoline HCI And Pheniramine Maleate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59390-177_b78fd969-ee4c-0ea0-e053-2a95a90a480d
- Product NDC
- 59390-177
- Form
- SOLUTION/ DROPS
- Composition / generic term
- NAPHAZOLINE HYDROCHLORIDE , PHENIRAMINE MALEATE
- Labeler
- Altaire Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20101006
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPHAZOLINE HYDROCHLORIDE — .27 mg/mL
- PHENIRAMINE MALEATE — 3.15 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 15 mL in 1 BOTTLE, DROPPER (59390-177-13) · 59390-177-13
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →